Articles Tagged With: misoprostol
-
Reproductive Health Providers Prepare for Increased Capacity
Before voters in Ireland overturned a constitutional abortion ban, people had to travel to England and other places to obtain a safe and legal abortion. Soon, a large proportion of pregnant Americans will face the same choice. -
Study of Online Searches for Abortion Revealed High Rate of Self-Managed Abortion
People who face barriers to abortion care are more likely to attempt self-managed abortion, including taking actions that may be harmful physically, according to the results of a recent study. The findings are particularly relevant as an increasing number of American women have little or no access to safe and legal abortions in their communities or states. -
Reducing Barriers to Self-Managed Abortion Care
Self-managed abortion care could be far cheaper and easier to obtain than it is now in the United States, with legal barriers such as state laws banning mail-order abortion pills and the federal rule that still prevents pharmacies from selling mifepristone and misoprostol. -
Self-Managed Abortions Becoming More Important as Post-Roe Era Looms
More states are passing highly restrictive anti-abortion legislation that will lead more people to seek abortions out of state or that are self-managed. Advance provision of medication abortion pills is one way to empower women to make their own decisions in the privacy of their homes.
-
Vaginal Misoprostol vs. Prostaglandin E2 Pessary for Induction of Labor at Term
In this randomized, noninferiority, clinical trial of pregnant women who underwent induction of labor with misoprostol compared to dinoprostone, the rate of vaginal delivery within 24 hours was higher in the misoprostol group. Maternal satisfaction, assessed by a visual analog scale, also was higher. Although the noninferiority of dinoprostone to misoprostol could not be demonstrated, the clinical risk-to-benefit ratio justifies the use of both drugs.
-
Mifepristone as an Adjunct to Misoprostol for Pregnancy Termination
In this prospective, double-blind, randomized, placebo-controlled trial, pretreatment with 200 mg of mifepristone 24 to 48 hours before labor induction using misoprostol significantly reduced time to delivery among demised fetuses between 14 and 28 weeks of gestation. Maternal complications were equivalent in both groups.
-
Study Examines Failed Self-Managed Abortions in Texas
A recent study revealed that nearly 7% of women seeking abortion services at Texas facilities in 2012 and 2014 reported they had attempted to self-manage their abortion before visiting the clinic. In states like Texas, where most abortion clinics closed because of restrictive state laws, accessing an abortion clinic is challenging. Barriers to safe and legal abortions appeared to be associated with women attempting self-management of abortion.
-
A New Treatment for Early Pregnancy Loss
In a recent trial, researchers found that pretreatment with mifepristone followed by treatment with misoprostol resulted in a higher likelihood of successful management of first-trimester pregnancy loss than treatment with misoprostol alone. The rate of surgical evacuation also was reduced in the mifepristone pretreatment arm compared to the misoprostol-alone arm.
-
Management of Pain Associated With Intrauterine Device Placement
With long-acting reversible contraceptive methods (intrauterine devices and implants) showing an increased proportion of users each year at the expense of permanent and short-acting hormonal methods, it makes sense to consider how best to improve the IUD placement experience, particularly for young nulliparous women.